V. Nakintu
Research Subjects
V. Nakintu has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
A. Nsawotebbe
Central Laboratory of Public Health of the Ministry of Health of the Republic of Uganda
1 shared publication- Aleksandra Vasilevna Ivanova
Russian Research Anti-Plague Institute “Microbe
1 shared publication - Anna Yurievna Popova
Federal Service for Surveillance on Consumers Rights Protection and Human Wellbeing; Russian Medical Academy of Continuing Professional Education
1 shared publication C. Ntirandekura
Ministry of Public Health and AIDS Control of the Republic of Burundi
1 shared publication- E. M. Rodnikova
Infectious Diseases Clinical Hospital No. 1 of the Moscow City Department of Health
1 shared publication - Ekaterina V. Naidenova
Russian Research Anti-Plague Institute “Microbe
1 shared publication
Latest Publications
- Open Access
- 7 April 2025
- Published by Russian Research Anti-Plague Institute Microbe in Problems of Particularly Dangerous Infections
- No. 1,p. 96-104
Operational Experience of the Rospotrebnadzor Specialists during the Epidemic of Mpox in Eastern and Central Africa in 2024
The paper presents the results of work of the Russian and African experts on the study of the epidemiological and clinical features of mpox in some countries of Eastern (Republic of Rwanda, Uganda, Burundi) and Central (Republic of the Congo) Africa in the fall of 2024. An analysis of the epidemiological data obtained in the countries under consideration showed that in most cases, mpox was reported in patients of the pediatric age group. The disease was equally registered in both men and women. The clinical course of the disease was represented by mild and moderate severe forms. Severe cases of the disease have been reported only among patients with immunosuppression, untreated HIV infection or other somatic and/or infectious pathologies, as well as in children under 2 years of age. Pregnant patients also had a mild form of mpox. No deaths were reported. Monkey pox was accompanied with a simultaneous increase in cases of Varicella Zoster virus disease in the Republics of Burundi and Uganda. This circumstance often led to the registration of patients with that infection as suspected but unconfirmed cases of mpox. People with herpetic manifestations also fell into this category. Rospotrebnadzor specialists provided consulting and practical assistance to the African colleagues. Russian-made reagent kits for detecting DNA of the monkeypox virus using PCR were transferred to each country. Based on the results of the joint work, a number of relevant areas for studying the circulation of the causative agent of this infectious disease, the clinical and epidemiological features of it in the countries of East and Central Africa have been identified.
- 7 April 2025
- Published by Russian Research Anti-Plague Institute Microbe in Problems of Particularly Dangerous Infections
- No. 1,p. 96-104
Open AccessOperational Experience of the Rospotrebnadzor Specialists during the Epidemic of Mpox in Eastern and Central Africa in 2024
The paper presents the results of work of the Russian and African experts on the study of the epidemiological and clinical features of mpox in some countries of Eastern (Republic of Rwanda, Uganda, Burundi) and Central (Republic of the Congo) Africa in the fall of 2024. An analysis of the epidemiological data obtained in the countries under consideration showed that in most cases, mpox was reported in patients of the pediatric age group. The disease was equally registered in both men and women. The clinical course of the disease was represented by mild and moderate severe forms. Severe cases of the disease have been reported only among patients with immunosuppression, untreated HIV infection or other somatic and/or infectious pathologies, as well as in children under 2 years of age. Pregnant patients also had a mild form of mpox. No deaths were reported. Monkey pox was accompanied with a simultaneous increase in cases of Varicella Zoster virus disease in the Republics of Burundi and Uganda. This circumstance often led to the registration of patients with that infection as suspected but unconfirmed cases of mpox. People with herpetic manifestations also fell into this category. Rospotrebnadzor specialists provided consulting and practical assistance to the African colleagues. Russian-made reagent kits for detecting DNA of the monkeypox virus using PCR were transferred to each country. Based on the results of the joint work, a number of relevant areas for studying the circulation of the causative agent of this infectious disease, the clinical and epidemiological features of it in the countries of East and Central Africa have been identified.